November 06, 2023
The Health Resources and Service Administration overstepped its authority with its narrow interpretation of a "patient" eligible to receive discounted drugs from participating clinics under the 340B drug pricing program, a South Carolina federal judge has ruled, siding with Genesis HealthCare Inc. in its challenge to the agency's interpretation.